20 Apr 2026: The ISH has selected three recipients of its recent funding call to support independent clinical research on wearable wrist-cuff blood pressure technology.

The ISH call attracted 84 proposals from our members worldwide and is supported by a research grant from Huawei.

Proposals were evaluated by an independent review panel based on scientific relevance, novelty, feasibility, and potential clinical impact.

The three selected projects are shown below, and all will investigate clinical applications of the novel wearable wrist-cuff blood pressure Huawei Watch D2 in independent research trials.

Clinical utility of a wearable wrist BP monitoring device in hypertension management in a low- and middle-income setting

Lead investigator: Priyanga Ranasinghe (University of Colombo, Sri Lanka, and University of Edinburgh, UK)

This project will evaluate the clinical utility and real-world feasibility of integrating wearable wrist-cuff blood pressure monitoring into routine hypertension care in Sri Lanka. Using a comparative clinical study design, it will assess impacts on blood pressure control, patient adherence, and clinical decision-making versus standard home and clinic-based monitoring approaches.

Nocturnal blood pressure monitoring and circadian pattern detection using wearable technology

Lead investigator: Jing Liu (Peking University People’s Hospital, China)

This study will validate the accuracy of the Huawei Watch D2 for nocturnal blood pressure measurement and circadian pattern detection against ambulatory blood pressure monitoring during sleep. It aims to improve identification of high-risk nocturnal blood pressure patterns, an important but often under-assessed predictor of cardiovascular outcomes.

Wearable blood pressure monitoring during pharmacological weight loss in young adults with hypertension

Lead investigator: Carmel McEniery (University of Cambridge, UK)

This proof-of-concept study will investigate the use of wearable blood pressure monitoring alongside novel weight-loss therapies in young adults with obesity-related hypertension. The project will examine how blood pressure changes during treatment and evaluate the ability of wearable devices to capture dynamic, real-world cardiovascular responses.

ISH President George Stergiou said: “Congratulations to the three awardees. This was a highly competitive funding call, highlighting the growing importance of this area of research and the potential of novel wearable technologies to improve blood pressure monitoring and management. We look forward to seeing the outputs and impact of these innovative projects.”.